Scinovex
articleTop 1% cited

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.

Journal of Pharmacology and Experimental Therapeutics · 1994 · Vol. 270(1) · pp. 228–235
Nitric Oxide and Endothelin EffectsBosentanAgonistEndothelin receptorReceptorChemistryAntagonistPharmacologyEndocrinologyInternal medicineMedicine

MeSH terms

BosentanAdministration, OralAmino Acid SequenceAnimalsBinding, CompetitiveCricetinaeHumansInsectaIodine RadioisotopesKineticsMaleMolecular Sequence DataRabbitsRats, Inbred WKYSensitivity and Specificity
Citations
668
FWCI
31.31
field-weighted impact
References
0
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. · Scinovex